Supporting this relevance of IL-6, although the non-surviving severe COVID-19 patients had significantly higher levels of IL-6, there were no significant differences between the two groups of patients in the levels of sIL-6R and sgp130, indicating limited control of IL-6 activity. Here, IL6R is linked to COVID-19.